Mary Morrow

918 total citations
32 papers, 653 citations indexed

About

Mary Morrow is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Mary Morrow has authored 32 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 21 papers in Virology and 8 papers in Emergency Medicine. Recurrent topics in Mary Morrow's work include HIV/AIDS Research and Interventions (26 papers), HIV/AIDS drug development and treatment (22 papers) and HIV Research and Treatment (21 papers). Mary Morrow is often cited by papers focused on HIV/AIDS Research and Interventions (26 papers), HIV/AIDS drug development and treatment (22 papers) and HIV Research and Treatment (21 papers). Mary Morrow collaborates with scholars based in United States, Uganda and United Kingdom. Mary Morrow's co-authors include Samantha MaWhinney, José Castillo‐Mancilla, Peter L. Anderson, Jennifer J. Kiser, Lane R. Bushman, Edward M. Gardner, Jia‐Hua Zheng, Mustafa E. Ibrahim, Lucas Ellison and Stacey S. Coleman and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mary Morrow

31 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Morrow United States	15	544	309	197	95	57	32	653
Maria Martínez‐Rebollar Spain	13	507 0.9×	275 0.9×	233 1.2×	168 1.8×	16 0.3×	49	684
Alberto Borghetti Italy	13	573 1.1×	339 1.1×	138 0.7×	169 1.8×	22 0.4×	82	748
Hongxin Zhao China	12	286 0.5×	99 0.3×	134 0.7×	73 0.8×	86 1.5×	56	448
Robert Grossberg United States	12	368 0.7×	132 0.4×	186 0.9×	86 0.9×	74 1.3×	24	537
Mark Thrun United States	15	568 1.0×	115 0.4×	457 2.3×	31 0.3×	206 3.6×	29	692
Anita Janse van Rensburg South Africa	12	596 1.1×	341 1.1×	192 1.0×	177 1.9×	62 1.1×	17	788
Deborah Goldstein United States	12	213 0.4×	148 0.5×	127 0.6×	49 0.5×	29 0.5×	22	527
Baiba Berzins United States	16	630 1.2×	466 1.5×	183 0.9×	256 2.7×	92 1.6×	44	859
Eknath Naik United States	15	339 0.6×	132 0.4×	168 0.9×	127 1.3×	91 1.6×	40	626
Megha Mehrotra United States	14	458 0.8×	141 0.5×	285 1.4×	22 0.2×	107 1.9×	35	558

Countries citing papers authored by Mary Morrow

Since Specialization

Citations

This map shows the geographic impact of Mary Morrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Morrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Morrow more than expected).

Fields of papers citing papers by Mary Morrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Morrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Morrow. The network helps show where Mary Morrow may publish in the future.

Co-authorship network of co-authors of Mary Morrow

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Morrow. A scholar is included among the top collaborators of Mary Morrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Morrow. Mary Morrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Erlandson, Kristine M., Mary Morrow, Samantha MaWhinney, et al.. (2023). Energy balance and body composition after switch between integrase strand transfer inhibitors and doravirine among people with HIV. Journal of Antimicrobial Chemotherapy. 79(1). 179–185. 1 indexed citations

Morrow, Mary, Jacob J. Capin, Sarah E. Jolley, et al.. (2023). Using Wearable Technology to Quantify Physical Activity Recovery: Secondary Report From the AFTER (App-Facilitated Tele-Rehabilitation) Program for COVID-19 Survivors Randomized Study. JMIR Rehabilitation and Assistive Technologies. 10. e43436–e43436. 3 indexed citations

Castillo‐Mancilla, José, Mary Morrow, Peter W. Hunt, et al.. (2023). Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression. Open Forum Infectious Diseases. 10(5). ofad230–ofad230. 3 indexed citations

Morrow, Mary, Samantha MaWhinney, Stacey S. Coleman, et al.. (2022). Cumulative tenofovir diphosphate exposure in persons with HIV taking single‐ vs. multiple‐tablet regimens. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(8). 641–650.

Capin, Jacob J., Sarah E. Jolley, Mary Morrow, et al.. (2022). Safety, feasibility and initial efficacy of an app-facilitated telerehabilitation (AFTER) programme for COVID-19 survivors: a pilot randomised study. BMJ Open. 12(7). e061285–e061285. 41 indexed citations

Morrow, Mary, Samantha MaWhinney, Kristina M. Brooks, et al.. (2022). Improving the accuracy of adherence data collected using medication monitoring technology in clinical research. Contemporary Clinical Trials. 125. 107051–107051. 1 indexed citations

O’Keefe, James B., Mary Morrow, Colin A. Johnson, et al.. (2021). Postacute Sequelae of SARS-CoV-2 Infection and Impact on Quality of Life 1–6 Months After Illness and Association With Initial Symptom Severity. Open Forum Infectious Diseases. 8(8). ofab352–ofab352. 18 indexed citations

Johnson, Kelly A., David V. Glidden, José Castillo‐Mancilla, et al.. (2021). Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing. Open Forum Infectious Diseases. 8(7). ofab200–ofab200. 7 indexed citations

Castillo‐Mancilla, José, Mary Morrow, Stacey S. Coleman, et al.. (2021). Low-Level Viremia Is Associated With Cumulative Adherence to Antiretroviral Therapy in Persons With HIV. Open Forum Infectious Diseases. 8(9). ofab463–ofab463. 20 indexed citations

10.

Mann, Sarah, Mary Morrow, Stacey S. Coleman, et al.. (2020). Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus. JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(4). 483–488. 7 indexed citations

11.

Brooks, Kristina M., José Castillo‐Mancilla, Mary Morrow, et al.. (2020). Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD Study. Open Forum Infectious Diseases. 8(1). ofaa564–ofaa564. 13 indexed citations

12.

Brooks, Kristina M., José Castillo‐Mancilla, Mary Morrow, et al.. (2020). Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir. Journal of Antimicrobial Chemotherapy. 75(11). 3303–3310. 7 indexed citations

13.

Schneck, Christopher D., Mary Morrow, Stacey S. Coleman, et al.. (2019). Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral Therapy. AIDS and Behavior. 23(12). 3493–3502. 16 indexed citations

14.

Castillo‐Mancilla, José, Stacey S. Coleman, Mary Morrow, et al.. (2019). Short Communication: Cascade of Antiretroviral Therapy Adherence in Virologically Suppressed Persons Living with HIV. AIDS Research and Human Retroviruses. 36(3). 173–175. 4 indexed citations

15.

Musinguzi, Nicholas, José Castillo‐Mancilla, Mary Morrow, et al.. (2019). Antiretroviral Therapy Adherence Interruptions Are Associated With Systemic Inflammation Among Ugandans Who Achieved Viral Suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 82(4). 386–391. 15 indexed citations

16.

Ibrahim, Mustafa E., Kristina M. Brooks, José Castillo‐Mancilla, et al.. (2018). Short Communication: Bioequivalence of Tenofovir and Emtricitabine After Coencapsulation with the Proteus Ingestible Sensor. AIDS Research and Human Retroviruses. 34(10). 835–837. 14 indexed citations

17.

Koss, Catherine A., Albert Liu, José Castillo‐Mancilla, et al.. (2018). Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine. AIDS. 32(15). 2189–2194. 13 indexed citations

18.

Castillo‐Mancilla, José, Mary Morrow, Yap Boum, et al.. (2018). Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 77(5). 507–513. 28 indexed citations

19.

Anderson, Peter L., Albert Liu, José Castillo‐Mancilla, et al.. (2017). Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy. Antimicrobial Agents and Chemotherapy. 62(1). 190 indexed citations

20.

Verma, Anita, Steven M. Devine, Mary Morrow, et al.. (2003). Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir. Bone Marrow Transplantation. 31(9). 813–816. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact